A detailed history of First National Bank & Trust CO Of Newtown transactions in Amgen Inc stock. As of the latest transaction made, First National Bank & Trust CO Of Newtown holds 1,770 shares of AMGN stock, worth $592,684. This represents 0.11% of its overall portfolio holdings.

Number of Shares
1,770
Previous 1,805 1.94%
Holding current value
$592,684
Previous $513,000 7.8%
% of portfolio
0.11%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$262.75 - $319.31 $9,196 - $11,175
-35 Reduced 1.94%
1,770 $553,000
Q1 2024

Apr 29, 2024

SELL
$268.87 - $324.56 $4,301 - $5,192
-16 Reduced 0.88%
1,805 $513,000
Q4 2023

Jan 31, 2024

SELL
$255.7 - $288.46 $5,114 - $5,769
-20 Reduced 1.09%
1,821 $524,000
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $2,356 - $2,787
11 Added 0.6%
1,841 $408,000
Q4 2022

Jan 31, 2023

SELL
$229.03 - $291.01 $11,451 - $14,550
-50 Reduced 2.66%
1,830 $480,000
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $3,289 - $3,638
15 Added 0.8%
1,880 $454,000
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $19,104 - $22,383
-90 Reduced 4.6%
1,865 $396,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $23,358 - $25,914
-100 Reduced 4.87%
1,955 $476,000
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $99,859 - $116,370
-450 Reduced 17.96%
2,055 $511,000
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $64,914 - $77,301
-300 Reduced 10.7%
2,505 $576,000
Q1 2020

Apr 23, 2020

SELL
$182.24 - $241.7 $18,224 - $24,170
-100 Reduced 3.44%
2,805 $569,000
Q4 2018

Jan 18, 2019

SELL
$178.4 - $208.25 $16,948 - $19,783
-95 Reduced 3.17%
2,905 $566,000
Q3 2017

Oct 25, 2017

BUY
$167.29 - $191.0 $501,870 - $573,000
3,000
3,000 $559,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $179B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track First National Bank & Trust CO Of Newtown Portfolio

Follow First National Bank & Trust CO Of Newtown and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank & Trust CO Of Newtown, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank & Trust CO Of Newtown with notifications on news.